+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

How much insulin-like growth factor-I (IGF-I) circulates?: impact of standardization on IGF-I assay accuracy



How much insulin-like growth factor-I (IGF-I) circulates?: impact of standardization on IGF-I assay accuracy



Developments in Biological Standardization 97: 111-118



Insulin-like growth factor-I (IGF-I, somatomedin-C) is a peptide hormone which plays an important role in growth regulation. Accurate measurements of circulating IGF-I levels in plasma samples are an important part of many studies on growth and development, and therefore many assays have been developed for this purpose. We have found that assay standardization has a major impact on IGF-I quantification. Most IGF-I assays are calibrated against the World Health Organization (WHO) International Reference Reagent (IRR) for IGF-I Immunoassays (87/518). The protein content assigned to WHO IRR 87/518 was a consensus value from a multicentre WHO collaborative study. Here we present physico-chemical data showing that WHO IRR 87/518 is Met(-1) IGF-I of low purity (44%), and that the assigned protein content is somewhat higher than the <> value determined by quantitative amino acid analysis. We show that assays calibrated against WHO IRR 87/518 report total IGF-I concentrations that are in excess of actual values by approximately two-fold. For this reason much of the IGF-I concentration data in the literature, which are based on assays calibrated against WHO IRR 87/518, are of questionable accuracy.

(PDF emailed within 1 workday: $29.90)

Accession: 046280198

Download citation: RISBibTeXText

PMID: 10463537


Related references

How much insulin-like growth factor-I circulates? Impact of standardization on IGF-I assay accuracy. Brown, F , Mire-Sluis, T Developments in Biological Standardization; Biological characterization and assay of cytokines and growth factors 111-118, 1999

How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy. Journal of Clinical Endocrinology and Metabolism 83(4): 1211-1216, 1998

Evidence that insulin like growth factor i prohormone circulates in renal failure. Pediatric Research 20(4 PART 2): 219A, 1986

Impact of testosterone assay standardization efforts assessed via accuracy-based proficiency testing. Clinical Biochemistry 2019, 2019

Impact of insulin resistance on insulin-like growth factor-1/insulin like growth factor-binding protein-3 axis and on early weight gain in small for gestational age infants. Journal of Clinical Research in Pediatric Endocrinology 5(2): 104-109, 2014

Insulin-like growth factor-I and insulin-like growth factor binding protein-3 cotreatment versus insulin-like growth factor-I alone in two brothers with growth hormone insensitivity syndrome: effects on insulin sensitivity, body composition and linear growth. Hormone Research in Paediatrics 76(5): 355-366, 2012

Radioligand binding assay of epidermal growth factor receptor: causes of variability and standardization of the assay. Clinical Chemistry 36(6): 849-854, 1990

Specific assay for insulin like growth factor ii using the insulin like growth factor binding proteins extracted from human cerebrospinal fluid. Journal of Clinical Endocrinology & Metabolism 63(5): 1151-1155, 1986

Time dependent impact of perinatal hypoxia on growth hormone, insulin-like growth factor 1 and insulin-like growth factor binding protein-3. Metabolic Brain Disease 31(4): 827-835, 2018

Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor beta, soluble Fas, and superoxide dismutase activity for the JACC study. Journal of Epidemiology 15 Suppl 1(): S67-S73, 2005

Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma. Cytokine 68(1): 50-58, 2014

Impact of nutrients on insulin-like growth factor-I, insulin-like growth factor binding protein-3 and their ratio in African American and white males. Public Health Nutrition 10(1): 97-105, 2007

The bovine placenta: a specific radioreceptor assay for both insulin-like growth factor I and insulin-like growth factor II. Acta Endocrinologica 118(2): 306-313, 1988

Insulin-like growth factor II (IGF-II) inhibits insulin-like growth factor binding protein I (IGFBP-1) production in luteinized human granulosa cells with a potency similar to insulin-like growth factor I (IGF-I) and higher than insulin. Journal of Clinical Endocrinology and Metabolism 81(9): 3412-3414, 1996

Impact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia. Leukemia and Lymphoma 56(11): 3135-3142, 2016